Exhibit 99.1(b)3
CONSOLIDATED BALANCE SHEETS
NDCHealth Corporation and Subsidiaries
(In thousands, except share data)
| | November 29, 2002
| | | May 31, 2003
| |
ASSETS | | | | | | | | |
Current assets: | | | | | | | | |
Cash and cash equivalents | | $ | 97,388 | | | $ | 13,447 | |
|
Accounts receivable | | | 80,738 | | | | 76,161 | |
Allowance for doubtful accounts | | | (7,939 | ) | | | (5,710 | ) |
| |
|
|
| |
|
|
|
Accounts receivable, net | | | 72,799 | | | | 70,451 | |
| |
|
|
| |
|
|
|
Income tax receivable | | | 174 | | | | 2,229 | |
Deferred income taxes | | | 8,539 | | | | 19,987 | |
Prepaid expenses and other current assets | | | 26,090 | | | | 23,258 | |
| |
|
|
| |
|
|
|
Total current assets | | | 204,990 | | | | 129,372 | |
| |
|
|
| |
|
|
|
Restricted cash | | | 145,875 | | | | — | |
Property and equipment, net | | | 111,400 | | | | 101,566 | |
Intangible assets, net | | | 379,684 | | | | 377,322 | |
Deferred income taxes | | | 19,564 | | | | 21,403 | |
Investments | | | 13,748 | | | | 13,497 | |
Other | | | 27,796 | | | | 15,024 | |
| |
|
|
| |
|
|
|
Total Assets | | $ | 903,057 | | | $ | 658,184 | |
| |
|
|
| |
|
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY | | | | | | | | |
Current liabilities: | | | | | | | | |
Line of credit | | $ | — | | | $ | 91,000 | |
Short-term borrowings | | | — | | | | 11,906 | |
Current portion of long-term debt | | | 8,439 | | | | 963 | |
Obligations under capital leases | | | 1,499 | | | | 1,296 | |
Accounts payable and accrued liabilities | | | 68,130 | | | | 76,047 | |
Deferred income | | | 20,661 | | | | 21,089 | |
| |
|
|
| |
|
|
|
Total current liabilities | | | 98,729 | | | | 202,301 | |
| |
|
|
| |
|
|
|
Long-term debt | | | 468,094 | | | | 151,910 | |
Obligations under capital leases | | | 1,144 | | | | 1,779 | |
Deferred income | | | 8,460 | | | | — | |
Other long-term liabilities | | | 22,252 | | | | 22,592 | |
| |
|
|
| |
|
|
|
Total liabilities | | | 598,679 | | | | 378,582 | |
| |
|
|
| |
|
|
|
Commitments and contingencies | | | | | | | | |
|
Minority interest in equity of subsidiaries | | | 20,790 | | | | 21,856 | |
|
Stockholders’ equity: | | | | | | | | |
Preferred stock, par value $1.00 per share; 1,000,000 shares authorized, none issued | | | — | | | | — | |
Common stock, par value $.125 per share; 200,000,000 shares authorized; 34,763,382 and 34,643,922 shares issued, respectively. | | | 4,345 | | | | 4,330 | |
Capital in excess of par value | | | 213,559 | | | | 212,026 | |
Retained earnings | | | 75,258 | | | | 54,194 | |
Deferred compensation and other | | | (5,826 | ) | | | (6,743 | ) |
Other comprehensive income | | | (3,748 | ) | | | (6,061 | ) |
| |
|
|
| |
|
|
|
Total stockholders’ equity | | | 283,588 | | | | 257,746 | |
| |
|
|
| |
|
|
|
Total Liabilities and Stockholders’ Equity | | $ | 903,057 | | | $ | 658,184 | |
| |
|
|
| |
|
|
|